Kiniksa Pharmaceuticals
KNSA
KNSA
52 hedge funds and large institutions have $385M invested in Kiniksa Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 15 reducing their positions, and 12 closing their positions.
Holders
52
Holders Change
-3
Holders Change %
-5.45%
% of All Funds
1.16%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
9
Increased
15
Reduced
15
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$25.5M |
| 2 |
2
BlackRock
New York
|
$18.1M |
| 3 |
DM
3
Deerfield Management
New York
|
$31.7M |
| 4 |
4
Invesco
Atlanta,
Georgia
|
$1.25M |
| 5 |
SIM
5
Spark Investment Management
New York
|
$561K |
